Display options
Cite
Schellongowski P, Sperr WR, Wohlfarth P, et al. Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review. ESMO Open. 2016;1(5):e000018doi: 10.1136/esmoopen-2015-000018.
Schellongowski, P., Sperr, W. R., Wohlfarth, P., Knoebl, P., Rabitsch, W., Watzke, H. H., & Staudinger, T. (2016). Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review. ESMO open, 1(5), e000018. https://doi.org/10.1136/esmoopen-2015-000018
Schellongowski, Peter, et al. "Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review." ESMO open vol. 1,5 (2016): e000018. doi: https://doi.org/10.1136/esmoopen-2015-000018
Schellongowski P, Sperr WR, Wohlfarth P, Knoebl P, Rabitsch W, Watzke HH, Staudinger T. Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review. ESMO Open. 2016 Sep 13;1(5):e000018. doi: 10.1136/esmoopen-2015-000018. eCollection 2016. PMID: 27843637; PMCID: PMC5070251.
Copy Download .nbib Format: NLM
Share it on

ESMO Open. 2016 Sep 13;1(5):e000018. doi: 10.1136/esmoopen-2015-000018. eCollection 2016.

Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review.

ESMO open

Peter Schellongowski, Wolfgang R Sperr, Philipp Wohlfarth, Paul Knoebl, Werner Rabitsch, Herbert H Watzke, Thomas Staudinger

Affiliations

  1. Department of Medicine I, Intensive Care Unit 13i2 , Medical University of Vienna , Vienna , Austria.
  2. Department of Medicine I, Clinical Division of Hematology and Hemostaseology , Medical University of Vienna , Vienna , Austria.
  3. Department of Medicine I, Bone Marrow Transplantation , Medical University of Vienna , Vienna , Austria.
  4. Department of Internal Medicine I, Division of Palliative Medicine , Medical University of Vienna , Vienna , Austria.

PMID: 27843637 PMCID: PMC5070251 DOI: 10.1136/esmoopen-2015-000018

Abstract

This narrative review deals with the challenge of defining adequate therapy goals and intensive care unit (ICU) admission criteria for critically ill patients with cancer. Several specific complications of critically ill patients with cancer require close collaborations of intensive care and cancer specialists. Intensivists require a basic understanding of the pathophysiology, diagnosis and therapy of common cancer-specific problems. Cancer specialists must be knowledgeable in preventing, detecting and treating imminent or manifest organ failures. In case of one or more organ dysfunctions, ICU admissions must be evaluated early. In order to properly define the therapy goals for critically ill patients with cancer, decision-makers must be aware of the short-term intensive care prognosis as well as the long-term oncological options and perspectives. Multidisciplinary teamwork is key when it comes down to decisions on ICU admission, planning of therapeutic aims, patient management in the ICU and tailored therapy limiting with smooth transition into a palliative care (PC) setting, whenever appropriate.

Keywords: admission criteria; cancer; intensive care unit; palliative care

Conflict of interest statement

Conflicts of Interest: None declared.

References

  1. Leuk Lymphoma. 2016 Aug;57(8):1831-8 - PubMed
  2. Leuk Lymphoma. 2013 Aug;54(8):1724-9 - PubMed
  3. Blood Rev. 2015 Nov;29(6):359-67 - PubMed
  4. Crit Care. 2009;13(1):R15 - PubMed
  5. Am J Respir Crit Care Med. 2010 Oct 15;182(8):1038-46 - PubMed
  6. Support Care Cancer. 2013 Mar;21(3):727-34 - PubMed
  7. BMC Cancer. 2010 Nov 08;10:612 - PubMed
  8. JAMA Oncol. 2015 Nov;1(8):1078-85 - PubMed
  9. N Engl J Med. 2015 Jun 4;372(23 ):2185-96 - PubMed
  10. Crit Care Med. 2008 Mar;36(3):690-6 - PubMed
  11. JAMA. 2011 Dec 28;306(24):2694-703 - PubMed
  12. JAMA. 2008 May 21;299(19):2294-303 - PubMed
  13. J Clin Oncol. 2012 Mar 10;30(8):880-7 - PubMed
  14. JAMA. 2015 Oct 27;314(16):1711-9 - PubMed
  15. Crit Care Med. 2007 Mar;35(3):808-14 - PubMed
  16. JAMA. 2016 Jan 19;315(3):284-92 - PubMed
  17. Am J Respir Crit Care Med. 1999 Dec;160(6):1957-61 - PubMed
  18. N Engl J Med. 2007 Feb 1;356(5):469-78 - PubMed
  19. J Clin Oncol. 2005 Jul 1;23(19):4406-13 - PubMed
  20. J Gen Intern Med. 2008 Nov;23(11):1871-6 - PubMed
  21. Leuk Lymphoma. 2012 Jul;53(7):1352-9 - PubMed
  22. Intensive Care Med. 2014 Aug;40(8):1173-4 - PubMed
  23. Intensive Care Med. 2014 Aug;40(8):1106-14 - PubMed
  24. Intensive Care Med. 2013 Feb;39(2):292-301 - PubMed
  25. Intensive Care Med. 2002 Dec;28(12):1775-80 - PubMed
  26. Intensive Care Med. 2004 May;30(5):965-71 - PubMed
  27. Crit Care Med. 2012 Jan;40(1):43-9 - PubMed
  28. Haematologica. 2011 Feb;96(2):231-7 - PubMed
  29. J Clin Oncol. 2013 Aug 1;31(22):2810-8 - PubMed
  30. Crit Care Med. 2001 Feb;29(2):277-82 - PubMed
  31. Bone Marrow Transplant. 2012 Apr;47(4):574-80 - PubMed
  32. Cancer. 2009 Jan 15;115(2):437-45 - PubMed
  33. Intensive Care Med. 2015 Nov;41(11):2008-10 - PubMed
  34. Intensive Care Med. 2010 Oct;36(10):1666-74 - PubMed
  35. Crit Care Clin. 2010 Jan;26(1):21-40 - PubMed
  36. Crit Care Med. 2007 Jun;35(6):1530-5 - PubMed
  37. Intensive Care Med. 2014 Oct;40(10):1409-28 - PubMed
  38. Crit Care Med. 2002 Oct;30(10):2260-70 - PubMed
  39. Ann Intensive Care. 2011 Mar 23;1(1):5 - PubMed
  40. Ann Intensive Care. 2015 Dec;5(1):28 - PubMed
  41. Crit Care Med. 2000 May;28(5):1322-8 - PubMed
  42. Intensive Care Med. 1999 Dec;25(12):1395-401 - PubMed
  43. Ann Hematol. 2014 Oct;93(10):1629-36 - PubMed
  44. Crit Care Med. 2013 Feb;41(2):580-637 - PubMed
  45. Intensive Care Med. 2013 May;39(5):889-98 - PubMed
  46. Am J Respir Crit Care Med. 2009 Nov 1;180(9):853-60 - PubMed

Publication Types